However, patients with diabetes should regularly monitor their blood sugar to ensure stability, as individual responses can vary
That does not guarantee an individual will lose more on the second drug, but average response is higher
However, the use of this medication in brittle diabetics or diabetics with large sugar fluctuations and those with low blood pressure should be done in conjunction with the patients primary care provider or endocrinologist, according to Tolkachjov
Ozempic (semaglutide) is a GLP-1 injection that helps to treat Type 2 diabetes
Changes in free insulin-like growth factor-1 and leptin concentrations during acute metabolic decompensation in insulin withdrawn patients with type 1 diabetes
GI symptom rates at the 12 mg dose included nausea (38-43%), diarrhea (33-35%), constipation (21-25%), and vomiting (20-21%)